Interaction Checker

Interaksi Koriogonadotropin alfa

Koriogonadotropin alfa (Ovidrel) memiliki 60 interaksi terdokumentasi dalam label FDA dan lembar fakta yang kami indeks: 37 mayor, 23 moderat, 0 minor, dan 0 dengan label yang melaporkan tidak ada interaksi bermakna. Setiap entri di bawah ini mengutip kalimat yang mendasarinya. Halaman obat ini adalah titik awal, bukan putusan untuk situasi Anda.

Interaksi dari label

Interaksi mayor (37)

  • Amiloriddiuretik hemat kaliumMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Asam etakrinatdiuretik loopMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Asetazolamidpenghambat karbonat anhidraseMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Atenolol dan klortalidonpenyekat betaMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Benazepril dan hidroklorotiazidpenghambat ACEMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Bisoprolol dan hidroklorotiazidpenyekat betaMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Bumetaniddiuretik loopMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Enalapril dan hidroklorotiazidpenghambat ACEMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Eplerenonantagonis aldosteronMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Fosinopril dan hidroklorotiazidpenghambat ACEMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Furosemiddiuretik loopMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Hidroklorotiaziddiuretik tiazidMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Indapamiddiuretik tiazidMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Irbesartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Mayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Kandesartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Mayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Klorotiaziddiuretik tiazidMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Klortalidondiuretik tiazidMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Kuinapril dan hidroklorotiazidpenghambat ACEMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Levotiroksinhormon tiroidMayor

    Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders). (label Koriogonadotropin alfa, Kontraindikasi)

  • Levotiroksin dan liotironinhormon tiroidMayor

    Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders). (label Koriogonadotropin alfa, Kontraindikasi)

  • Liotironinhormon tiroidMayor

    Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders). (label Koriogonadotropin alfa, Kontraindikasi)

  • Lisinopril dan hidroklorotiazidpenghambat ACEMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Losartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Mayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Metolazondiuretik tiazidMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Metoprolol dan hidroklorotiazidpenyekat betaMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Olmesartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Mayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Olmesartan, amlodipin, dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Mayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Propiltiourasilobat antitiroidMayor

    Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders). (label Koriogonadotropin alfa, Kontraindikasi)

  • Spironolaktonantagonis aldosteronMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Spironolakton dan hidroklorotiazidantagonis aldosteronMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Telmisartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Mayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Teriparatidhormon tiroidMayor

    Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders). (label Koriogonadotropin alfa, Kontraindikasi)

  • Tiamazolobat antitiroidMayor

    Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders). (label Koriogonadotropin alfa, Kontraindikasi)

  • Torasemiddiuretik loopMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Triamterendiuretik hemat kaliumMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Triamteren dan hidroklorotiaziddiuretik hemat kaliumMayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Valsartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Mayor

    Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

Interaksi moderat (23)

  • BikalutamidandrogenModerat

    PRECAUTIONS General Induction of androgen secretion by hCG may cause fluid retention. (label Koriogonadotropin alfa, Perhatian)

  • DanazolandrogenModerat

    PRECAUTIONS General Induction of androgen secretion by hCG may cause fluid retention. (label Koriogonadotropin alfa, Perhatian)

  • Desogestrel dan etinilestradiolkontrasepsi oralModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • Drospirenon dan etinilestradiolkontrasepsi oralModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • EstradiolestrogenModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • Estradiol dan dienogestkontrasepsi oralModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • Estradiol dan noretisteronestrogenModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • Estrogen teresterifikasi dan metiltestosteronestrogenModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • Estrogen terkonjugasiestrogenModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • Estrogen terkonjugasi dan bazedoksifenestrogenModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • Etinodiol diasetat dan etinilestradiolkontrasepsi oralModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • Etonogestrel dan etinilestradiolestrogenModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • FlutamidandrogenModerat

    PRECAUTIONS General Induction of androgen secretion by hCG may cause fluid retention. (label Koriogonadotropin alfa, Perhatian)

  • FulvestrantestrogenModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • Gonadotropin korionikModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • Levonorgestrel dan etinilestradiolkontrasepsi oralModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • MetiltestosteronandrogenModerat

    PRECAUTIONS General Induction of androgen secretion by hCG may cause fluid retention. (label Koriogonadotropin alfa, Perhatian)

  • Norelgestromin dan etinilestradiolestrogenModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • Noretisteron dan etinilestradiolkontrasepsi oralModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • Norgestimat dan etinilestradiolkontrasepsi oralModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • Norgestrel dan etinilestradiolkontrasepsi oralModerat

    Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (label Koriogonadotropin alfa, Peringatan)

  • ProgesteronprogestinModerat

    The indices most generally used are as follows: A rise in basal body temperature Increase in serum progesterone and Menstruation following a shift in basal body temperature Urinary or serum luteinizing hormone (LH) rise When used in conjunction with the indices of progesterone production, sonographic visualization of the ovaries will assist in determining if… (label Koriogonadotropin alfa, Perhatian)

  • TestosteronandrogenModerat

    PRECAUTIONS General Induction of androgen secretion by hCG may cause fluid retention. (label Koriogonadotropin alfa, Perhatian)

Periksa Koriogonadotropin alfa terhadap semua yang Anda gunakan. Tambahkan seluruh daftar Anda; setiap pasangan diperiksa sekaligus.

Buka di pemeriksa

Bukan nasihat medis. Tingkat keparahan mencerminkan kata-kata dalam label, bukan keadaan Anda. Tanda “mayor” bisa merupakan hal yang rutin di bawah pengawasan, dan tanda “minor” bisa menjadi penting pada dosis tinggi. Tanyakan kepada apoteker.